Pricing Cures For Sickle Cell Disease: Sen. Cassidy Weighs In

Price decisions based on straight calculation of medical costs avoided may overestimate value of a cure, Cassidy warns.

Sickle cell anemia, 3D illustration showing blood vessel with normal and deformated crescent-like red blood cells

More from Pricing Debate

More from Market Access